Article info

Download PDFPDF
Gross hematuria secondary to use of carboplatin in neoadjuvant treatment of breast cancer with HER2 overexpression

Authors

  • Julia Pastorello Department of Clinical Oncology, Hospital de Clínicas de Passo Fundo - HCPF, Passo Fundo, Rio Grande do Sul, BrazilAcademic League of Oncology and Hematology - LAONC - HCPF, Hospital de Clínicas de Passo Fundo - HCPF, Passo Fundo, Rio Grande do Sul, Brazil PubMed articlesGoogle scholar articles
  • Nicolas Almeida Leal da Silva Department of Urology, Hospital de Clínicas de Passo Fundo - HCPF, Passo Fundo, Rio Grande do Sul, Brazil PubMed articlesGoogle scholar articles
  • Natalia Bassani Schuch Department of Nephrology, Hospital de Clínicas de Passo Fundo - HCPF, Passo Fundo, Rio Grande do Sul, Brazil PubMed articlesGoogle scholar articles
  • Emanuela Lando Academic League of Oncology and Hematology - LAONC - HCPF, Hospital de Clínicas de Passo Fundo - HCPF, Passo Fundo, Rio Grande do Sul, Brazil PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Julia Pastorello; Julia.pastorello{at}yahoo.com.br
View Full Text

Citation

Pastorello J, da Silva NAL, Schuch NB, et al
Gross hematuria secondary to use of carboplatin in neoadjuvant treatment of breast cancer with HER2 overexpression

Publication history

  • Accepted June 7, 2022
  • First published September 6, 2022.
Online issue publication 
September 06, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.